Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07165080Completed

Comparative Evaluation of smART+ REE Module to an FDA-cleared Device, for REE Calculation in ICU Patients

Role: lead

NCT04098224Not ApplicableCompleted

Nutrition Monitoring and Feeding Optimization With the smART+ System - Comparative Study

Role: lead

NCT03198988Terminated

Functionality and Accuracy of the smART System in Real-Life ICU Settings

Role: lead

NCT02705781Not ApplicableCompleted

Functionality and Accuracy of the smARTrack System in Real-Life ICU Settings

Role: lead

All 4 trials loaded